Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
351.52
-3.78 (-1.06%)
Apr 20, 2026, 1:45 PM EDT - Market open
Amgen Employees
Amgen had 31,500 employees as of December 31, 2025. The number of employees increased by 3,500 or 12.50% compared to the previous year.
Employees
31,500
Change (1Y)
3,500
Growth (1Y)
12.50%
Revenue / Employee
$1,166,698
Profits / Employee
$244,794
Market Cap
189.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 31,500 | 3,500 | 12.50% |
| Dec 31, 2024 | 28,000 | 1,300 | 4.87% |
| Dec 31, 2023 | 26,700 | 1,500 | 5.95% |
| Dec 31, 2022 | 25,200 | 1,000 | 4.13% |
| Dec 31, 2021 | 24,200 | -100 | -0.41% |
| Dec 31, 2020 | 24,300 | 900 | 3.85% |
| Dec 31, 2019 | 23,400 | 1,900 | 8.84% |
| Dec 31, 2018 | 21,500 | 700 | 3.37% |
| Dec 31, 2017 | 20,800 | 1,600 | 8.33% |
| Dec 31, 2016 | 19,200 | 1,300 | 7.26% |
| Dec 31, 2015 | 17,900 | 0 | - |
| Dec 31, 2014 | 17,900 | -2,100 | -10.50% |
| Dec 31, 2013 | 20,000 | 2,000 | 11.11% |
| Dec 31, 2012 | 18,000 | 200 | 1.12% |
| Dec 31, 2011 | 17,800 | 400 | 2.30% |
| Dec 31, 2010 | 17,400 | 200 | 1.16% |
| Dec 31, 2009 | 17,200 | 300 | 1.78% |
| Dec 31, 2008 | 16,900 | -600 | -3.43% |
| Dec 31, 2007 | 17,500 | -2,600 | -12.94% |
| Dec 31, 2006 | 20,100 | 3,600 | 21.82% |
| Dec 31, 2005 | 16,500 | 2,100 | 14.58% |
| Dec 31, 2004 | 14,400 | 1,500 | 11.63% |
| Dec 31, 2003 | 12,900 | 2,800 | 27.72% |
| Dec 31, 2002 | 10,100 | 2,400 | 31.17% |
| Dec 31, 2001 | 7,700 | 400 | 5.48% |
| Dec 31, 2000 | 7,300 | 900 | 14.06% |
| Dec 31, 1999 | 6,400 | 900 | 16.36% |
| Dec 31, 1998 | 5,500 | 192 | 3.62% |
| Dec 31, 1997 | 5,308 | 662 | 14.25% |
| Dec 31, 1996 | 4,646 | 600 | 14.83% |
| Dec 31, 1995 | 4,046 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
AMGN News
- 10 days ago - Amgen's lung cancer drug tarlatamab wins China approval - Reuters
- 12 days ago - 15 stocks to put on your list to buy when the market recovers - Market Watch
- 14 days ago - Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study. - Barrons
- 14 days ago - AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE - PRNewsWire
- 17 days ago - Swiss industry body says US tariffs on pharmaceuticals will harm patients - Reuters
- 17 days ago - Trump Administration Unveils Up to 100% Tariff on Branded Drugs - WSJ
- 17 days ago - Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices - The Guardian
- 17 days ago - Drugmakers face 100% tariff unless they cut prices or produce drugs in US - Reuters